Results 181 to 190 of about 108,380,509 (205)

Novel Triple Neurokinin Receptor Antagonist CS-003 Strongly Inhibits Neurokinin Related Responses

European Journal of Pharmacology, 2008
Makoto Yamashita
exaly  

Phase 2 Trial of a Neurokinin-1 Receptor Antagonist for the Treatment of Chronic Itch in Patients With Epidermolysis Bullosa: A Randomized Clinical Trial

Journal of the American Academy of Dermatology, 2020
Sara Choi, Jean Y Tang, Albert Chiou
exaly  

Aprepitant: A Neurokinin-1 Receptor Antagonist for the Treatment of Chemotherapy-Induced Nausea and Vomiting

Expert Review of Anticancer Therapy, 2004

exaly  

RADIOLABELED NEUROKININ-1 RECEPTOR ANTAGONISTS

2004
BURNS H DONALD, ENG WAI-SI, GIBSON RAYMOND E, HAMILL TERENCE G   +3 more
openaire   +3 more sources

RADIOLABELED NEUROKININ-1 RECEPTOR ANTAGONISTS

2008
BURNS H DONALD, GIBSON RAYMOND E, HAMILL TERENCE G   +2 more
openaire   +2 more sources

Nonpeptide Tachykinin Receptor Antagonists: I. Pharmacological and Pharmacokinetic Characterization of SB 223412, a Novel, Potent and Selective Neurokinin-3 Receptor Antagonist

Journal of Pharmacology and Experimental Therapeutics, 1997
Nabil A Elshourbagy, Douglas W P Hay, H M Sarau   +2 more
exaly  

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

New England Journal of Medicine, 1999
Richard J Gralla, Paul J Hesketh
exaly  

Neurokinin 3 Receptor Antagonist Revival Heats Up With Astellas Acquisition

Nature Reviews Drug Discovery, 2017
Megan Cully
exaly  

Prevention of cisplatin-induced emesis by a neurokinin-1-receptor antagonist.

The New England journal of medicine, 1999
F, Roila, E, Ballatori, A, Del Favero
openaire   +2 more sources

Fosaprepitant (MK-0517): A Neurokinin-1 Receptor Antagonist for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Expert Opinion on Investigational Drugs, 2007

exaly